Tennessee Oncology-Chattanooga ( Site 0045) — Chattanooga, Tennessee

Tennessee Oncology-Chattanooga ( Site 0045) is a clinical research site located in Chattanooga, Tennessee, United States 37404.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Tennessee Oncology-Chattanooga ( Site 0045) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology-Chattanooga ( Site 0045)?

Tennessee Oncology-Chattanooga ( Site 0045) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology-Chattanooga ( Site 0045) conducted?

Tennessee Oncology-Chattanooga ( Site 0045) has 1 clinical trials on record, with 1 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Is Tennessee Oncology-Chattanooga ( Site 0045) accredited by Crixeo Health?

Tennessee Oncology-Chattanooga ( Site 0045) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology-Chattanooga ( Site 0045)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.